Premium
Letter: which patients with hepatitis B virus‐related hepatocellular carcinoma should receive nucleos(t)ide analogue therapy? Authors' reply
Author(s) -
Wong G. L.H.,
Wong V. W.S.
Publication year - 2016
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13778
Subject(s) - medicine , hepatocellular carcinoma , gastroenterology , guideline , hepatectomy , hepatitis b virus , chronic hepatitis , oncology , resection , surgery , virus , pathology , immunology